BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21373701)

  • 1. Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients.
    Li X; Ferrel GL; Guerra MC; Hode T; Lunn JA; Adalsteinsson O; Nordquist RE; Liu H; Chen WR
    Photochem Photobiol Sci; 2011 May; 10(5):817-21. PubMed ID: 21373701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of different components of laser immunotherapy in treatment of metastatic tumors in rats.
    Chen WR; Liu H; Ritchey JW; Bartels KE; Lucroy MD; Nordquist RE
    Cancer Res; 2002 Aug; 62(15):4295-9. PubMed ID: 12154032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant.
    Chen WR; Korbelik M; Bartels KE; Liu H; Sun J; Nordquist RE
    Photochem Photobiol; 2005; 81(1):190-5. PubMed ID: 15535737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phototherapy using immunologically modified carbon nanotubes to potentiate checkpoint blockade for metastatic breast cancer.
    Li Y; Li X; Doughty A; West C; Wang L; Zhou F; Nordquist RE; Chen WR
    Nanomedicine; 2019 Jun; 18():44-53. PubMed ID: 30844573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical effects of in situ photoimmunotherapy on late-stage melanoma patients: a preliminary study.
    Li X; Naylor MF; Le H; Nordquist RE; Teague TK; Howard CA; Murray C; Chen WR
    Cancer Biol Ther; 2010 Dec; 10(11):1081-7. PubMed ID: 20890121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of photothermal and photoimmunological reactions in treatment of metastatic tumors.
    Chen WR; Liu H; Carubelli R; Nordquist RE
    J Xray Sci Technol; 2002 Jan; 10(3):225-35. PubMed ID: 22388051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment.
    Chen WR; Adams RL; Carubelli R; Nordquist RE
    Cancer Lett; 1997 May; 115(1):25-30. PubMed ID: 9097975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laser immunotherapy: a novel treatment modality for metastatic tumors.
    Chen WR; Carubelli R; Liu H; Nordquist RE
    Mol Biotechnol; 2003 Sep; 25(1):37-44. PubMed ID: 13679633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IR 820 dye encapsulated in polycaprolactone glycol chitosan: Poloxamer blend nanoparticles for photo immunotherapy for breast cancer.
    Kumar P; Srivastava R
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():321-7. PubMed ID: 26354271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indocyanine green and poly I:C containing thermo-responsive liposomes used in immune-photothermal therapy prevent cancer growth and metastasis.
    Xu L; Zhang W; Park HB; Kwak M; Oh J; Lee PCW; Jin JO
    J Immunother Cancer; 2019 Aug; 7(1):220. PubMed ID: 31412934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective photothermal interaction using an 805-nm diode laser and indocyanine green in gel phantom and chicken breast tissue.
    Liu VG; Cowan TM; Jeong SW; Jacques SL; Lemley EC; Chen WR
    Lasers Med Sci; 2002; 17(4):272-9. PubMed ID: 12417982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of x-ray attenuation coefficients of aqueous solutions of indocyanine green and glycated chitosan.
    Xu F; Liu H; Wu X; Jiang H; Nordquist RE; Chen WR
    Med Phys; 1999 Jul; 26(7):1371-4. PubMed ID: 10435540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trial.
    Polgár C; Ott OJ; Hildebrandt G; Kauer-Dorner D; Knauerhase H; Major T; Lyczek J; Guinot JL; Dunst J; Miguelez CG; Slampa P; Allgäuer M; Lössl K; Polat B; Kovács G; Fischedick AR; Fietkau R; Resch A; Kulik A; Arribas L; Niehoff P; Guedea F; Schlamann A; Pötter R; Gall C; Uter W; Strnad V;
    Lancet Oncol; 2017 Feb; 18(2):259-268. PubMed ID: 28094198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term tumor resistance induced by laser photo-immunotherapy.
    Chen WR; Zhu WG; Dynlacht JR; Liu H; Nordquist RE
    Int J Cancer; 1999 May; 81(5):808-12. PubMed ID: 10328237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged administration of weekly paclitaxel and trastuzumab in patients with advanced breast cancer.
    Christodoulou C; Klouvas G; Pateli A; Mellou S; Sgouros J; Skarlos DV
    Anticancer Res; 2003; 23(1B):737-44. PubMed ID: 12680177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.
    Pernas S; Martin M; Kaufman PA; Gil-Martin M; Gomez Pardo P; Lopez-Tarruella S; Manso L; Ciruelos E; Perez-Fidalgo JA; Hernando C; Ademuyiwa FO; Weilbaecher K; Mayer I; Pluard TJ; Martinez Garcia M; Vahdat L; Perez-Garcia J; Wach A; Barker D; Fung S; Romagnoli B; Cortes J
    Lancet Oncol; 2018 Jun; 19(6):812-824. PubMed ID: 29706375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase I trial of ganetespib in combination with paclitaxel and trastuzumab in patients with human epidermal growth factor receptor-2 (HER2)-positive metastatic breast cancer.
    Jhaveri K; Wang R; Teplinsky E; Chandarlapaty S; Solit D; Cadoo K; Speyer J; D'Andrea G; Adams S; Patil S; Haque S; O'Neill T; Friedman K; Esteva FJ; Hudis C; Modi S
    Breast Cancer Res; 2017 Aug; 19(1):89. PubMed ID: 28764748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silibinin and indocyanine green-loaded nanoparticles inhibit the growth and metastasis of mammalian breast cancer cells in vitro.
    Sun HP; Su JH; Meng QS; Yin Q; Zhang ZW; Yu HJ; Zhang PC; Wang SL; Li YP
    Acta Pharmacol Sin; 2016 Jul; 37(7):941-9. PubMed ID: 27133295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutrophil infiltration and whole-cell vaccine elicited by N-dihydrogalactochitosan combined with NIR phototherapy to enhance antitumor immune response and T cell immune memory.
    Qi S; Lu L; Zhou F; Chen Y; Xu M; Chen L; Yu X; Chen WR; Zhang Z
    Theranostics; 2020; 10(4):1814-1832. PubMed ID: 32042338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. InCVAX--a novel strategy for treatment of late-stage, metastatic cancers through photoimmunotherapy induced tumor-specific immunity.
    Zhou F; Li X; Naylor MF; Hode T; Nordquist RE; Alleruzzo L; Raker J; Lam SS; Du N; Shi L; Wang X; Chen WR
    Cancer Lett; 2015 Apr; 359(2):169-77. PubMed ID: 25633839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.